Member Info for idg69

There is and never has been any question over the scale of the ED market, it's huge and growing bigger by the day as a result of the appalling mainstream western diet the world has adopted. That's one thing we can all agree upon on this board.

The big question are: Q1 Do FUM have the wonder product they say they have? Studies to date would indicate it's pretty good in most cases with few if any side effects. Q2 can they get the powers that be to sign off from a regulatory perspective? Time will tell. Q3 can they attract a big player to market and distribute said product? God knows (if there is one)

Meanwhile we are running out of operating funds and the news flow from the BoD is woeful at best. There's no question the market place would go **** a hoop for a fast acting highly effective topical ED gel but FUM need to pull their finger out now as patience is wearing thin after too many years have gone by.

One small comfort I can take from experience is that it always gets darker before the dawn. I traded and watched AFC from my buy in price of 22p down to just below 4p thinking it would go to the wall. The technology finally worked after years of development, the orders started to flow, big players took an interest and it has risen to a recent high of 85p. So I appreciate it can be done. Let's hope FUM can come good for all our sakes.

More blue than red on the board today but boy the elastic is getting tighter around the 15p mark. For a very volatile stock historically, it's hanging tight to the 15p mark. Does anyone out there know for sure if we are using Nicholas Hall as our corporate trade finding partner or is it just conjecture? Would be encouraging to know that we are working with the right people in sourcing a trade partner.

More importantly, any thoughts on valuations if the EU reject Med3000 for both OTC and/or prescription? With my pessimists pants on I can see the EU doing a FDA and requesting further testing/analysis before signing off. No approval on anything in the next 8-12 weeks and a fundraising on the cards will see this sub 10p.

Can't see the FDA 6 month trial getting underway until Q2 (April/May/June) at the earliest. We'll be lucky to see the results of the FDA trial this year and then they need to review the data and pontificate a little more - FDA approval will be 1st half of 2022 in my humble opinion.

I'd like to be pleasantly surprised by this stock for a change instead of continually disappointed. Today I be mostly feeling Blue about FUM.

Afternoon Bluechip, I appreciate your positive outlook but why do you think 'now is a fantastic opportunity to buy the shares at a great price' and not when we know what the company will be doing regarding raising funds in Q2?

We also have no news regards to any future partner agreements, EU approval or even a start date for the FDA trial. Do you not think now is a very sceptical time to commit more funds to this share? If we were fully funded for the next 2 years I would be considerably more confident about the companies future and agree now is an opportunity to buy. Wishing you well.

60p imminent - aren't shares brilliant! I've just sold a kidney and my first born child to raise more funds. I'm going all in on this one if 60p is around the corner, what's to lose? I may even take out a bank loan if the odds on 60p are looking that good.

Cheers Bruce, let me know when it starts to give a different reading. I think mine is frozen and needs a reboot.

A very quiet day on the board. Without wanting to give this stock the kiss of death, I am continually surprised by how the price is holding up at the 15p mark. Looking at the historical charts I can't see a time when this stock has stayed on the level for this long. Take out the Covid 1st lockdown dip and the subsequent rebound we are exactly where we were at the end of Dec 2019. Historically this has been quite a volatile stock but not now. With the delays and poor news flow we've had I would have expected this to drift back under 10p but it's certainly holding its own right now. It's not giving me much opportunity to buy on the dips as there aren't really any to speak of. Lets see what happens at the end of Qtr 1 and the beginning of Qtr 2. I'm buffing my crystal ball but it's giving nothing away.

Morning Bucolic, happy new year to you too, let's hope our fortunes change and for the better this year. I do understand it won't be FUM bringing this to market and their strategy is to partner with a major pharma co. I just hope the FUM BoD have the credibility and ear of the big players and we are talking to the right people now. Having a great product is one thing, getting it in front of the key players is another. Saying your strategy is to partner with a major player and that actually happening are two very different things. Only time will tell my friend. Wishing you well. idg69

Can't disagree with you there my friend, fair point well made Bucolic. Med3000's potential is off the charts in my view (if it really does what it's claimed to do) The burning question is, do FUM have the ability to bring that potential to market and launch a global class leading ED product. Pfizer did it successfully with Viagra which has considerably more drawbacks/side effects than our product, but I question whether a minnow like FUM will be able to do it. I am pleasantly surprised at how well the share price has held up in the 13-17p range for quite some time now. Let's see how the next Qtr pans out shall we when they come back to the market for more cash.

Ody07 - These are my sentiments to the letter. I think it will bounce 2p above and below the 15p mark for the foreseeable future and only when the next cash call is announced will it drop to the placing price or a tad below. Then when the company is a little more secure will we see the shares rise. They really need to push the FDA for sign off on the 6 month safety trial criteria and get that underway ASAP if we are to see any chance of a US partner in 2021 or early 2022. This is only my opinion based on what little knowledge I have on FUM. I'm here for the long haul now so quite prepared to average down on the dips and sit it out as long as solid progress is being made. Good luck all and all the very best for the year(s) ahead.

Couldn't be more disappointed with FUM at the moment but more disgruntled with the quality of chat and analysis on this board right now. If we are old enough to earn money to trade/invest on the stock market then we should all be above the petty playground slander and name calling going on here. A bit of light hearted leg pulling is one thing but recent posts are pitiful.
We all have differing opinions on this company and mine certainly change on a daily basis from despair to rare glimmers of optimism from time to time, but reading this board is embarrassing at times. Could we please all respect other peoples opinions and keep the petty squabbling out of things. Can we all be a little more rational, a lot less emotional and remain civil with one another.

' this board is the v.v.worst on LSE imo' - could not agree more.

'This could turn out the greatest ever investment on the LSE'
It could, but will it? Loving the optimism - let's all pile in and buy more at these prices it's the bargain of the century!
I like Pinkies idea of adding the illusive ingredient to pep up the lady parts, now that really would be a stella product.

Morning bald eagle, I think you’ve answered your own question there my friend. A successful product is one that goes on to sell and neither of FUMs products have sold, making them both very unsuccessful. It’s a poor track record for over 15 years in business.

Ananda you really do make my smile at times. Your boundless enthusiasm for this stock is admirable. I'm not giving any advice, I'm just calling it how I see it right now. This could turn on a sixpence if a commercial deal is signed with an upfront payment but I don't see that happening before either FDA or EMA approval and the past track record of the BoD isn't great. This means that the company have no option but to raise funds before the end of Q1 2021 - I don't think this is up for debate.

As far as I'm aware they haven't brought one product to a successful commercial launch. I'm happy to be corrected if I'm wrong on this. I accept there's a first time for everything and let's hope Med3000 is FUMs first product to market. I do admire your positive mental attitude and your glass half full temperament - keep it up. Wishing you well idg69

Apologies for being a doom-monger (realist) but any day gains will quickly evaporate when they come back to the market for more cash in Qtr 1 2021. They may even give us an early Christmas present and do a placing before the month end. I for one would be OK with that as at least we could enter 2021 knowing we can keep the lights on next year and we're fully funded for the FDA trial next year. Raising funds at 15p would be preferential to seeing this drift back and a cash call at 10-12p in Feb/March.

backinblak - I can't disagree with anything you say there my friend, specifically about what's holding the share price at these levels. My hunch is it will be further dilution in Qtr 1 2021. I've got funds to top up/average down but I'm holding off as I do think I'll get some more closer to 10p. I'm not deramping but I can't see a partner coming from nowhere to fund upcoming trials - what do you think?

No one can deny the success of Viagra, it was a game changer for many and a massive financial success for big Pharma. However it does have many many drawbacks, which are well documented and not for debate. Given the option of a topical gel with a 5-10 min onset and a superior safety profile that can be used as part of foreplay over a tablet that has to be taken hours in advance, it's a no brainer the gel would win hands down everytime. Anyone saying otherwise isn't being true to themselves. I don't think you can say Viagra would never be knocked off its perch (though it's a big task). If MED3000 does what it's claimed to do, even in 60-70% of ED cases it would become the ED medication of choice. The big IF is do FUM have the funds & expertise to bring this product to market or partner with the right people who can. I also question why a small independent like FUM have been developing this type of product for so long and the likes of Pfizer haven't (or have they? who knows). I hope this product isn't 'doomed to fail' as it's potentially the game changer that Viagra once was. ED is only going to rise (no pun intended) with the increase in population eating the appalling meat based processed fast food western diet so there is an ever growing market for such a product as MED3000 - I just hope and pray the FUM BoD have the expertise to bring this to market. I don't always disagree with Hawkhead and do sympathise/understand is slant on things at times, but I think you could be wrong on this one. Wishing you well idg69

I can't help but agree with your last post Hawkhead. I don't like to admit it but the picture you paint is pretty much where we are at right now. I've said before this is very much a black or red stock right now. I don't have a great deal of faith in the current BoD to deliver this wonder product to the market. I think it's potentially a fantastic product with a worldwide reach but will the current management be able to realise that potential and get this to market anytime soon. A lot more dilution is on the cards and you'd have to be a fool to think otherwise. The newsflow is also diabolical and does nothing for investor confidence. I wish I wasn't here but can't afford to take the losses I'm currently at so I'll just sit it out another 6-12 months and hope the worm can turn. Stranger things have happened. Might even average down in the spring when the placing happens - which I'm sure it will around Feb/Mar if not before.

Nothing to get excited about here. Any small day gains will be quickly eradicated Q1 2021 when they come back to the market cap in hand for more money. My prediction is a another placing at 10-12p before the end of March.